Medcura is a commercial-stage medical device company leveraging a proprietary platform to develop versatile hemostatic products for surgical, military and consumer applications. Medcura uses cost-effective, all-natural materials to produce high-performance bleeding management products that have been cleared by the US FDA for clinical and consumer applications, including the creation of antibacterial healing environments. Medcura’ s FDA-cleared vascular closure device (K143466) has clinically demonstrated reduction in the time to hemostasis and ambulation from the current standard of care (120 minutes) to an average of 40.5 minutes.
The company has executed a partnership to commercialize consumer products with the North American market leader in first-aid and wound are ( e.g. mfg and sells –4B adhesive bandages/year) that will support revenues from first products being shipped to CVS and other retail pharmacies this year.
Medcura combines the use of safe, inert ingredients with proprietary chemistry across a broad spectrum of clinical applications, with the Company’s innovative product Life Foam™ leading the expansion into internal military and surgical applications.
Radio Broadcast Feature
Begin listening at :45 in the podcast.
Medcura’ s management team and advisors have been hand-selected for their domain expertise in hemostatics and collectively have developed, financed, and monetized numerous medical devices and other life science products. Medcura has a diverse capital foundation, where almost 50% has come from non-dilutive sources including funding from the Department of Defense.
Get access to the important information you need from Farmers for Innovation. Using the fields below, please provide your information so that we may reach out regarding next steps and access to the FFI Data Room.